GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sun Pharma Advanced Research Co SPARC.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

210.80

+8.93%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

10 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 5Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 2,080.80

Low
2,060.40
Average
2,080.80
Median
2,080.80
High
2,142.00

Forecasts

Analyst averages for the fiscal years ahead

FY2027FY2028
Revenue₹665.26bn₹740.36bn
Revenue, highest₹687.43bn₹754.74bn
Revenue, lowest₹624.32bn₹704.42bn
Earnings per share63.91—
Earnings per share, highest71.72—
Earnings per share, lowest54.68—
Analysts54

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2025Q4 2023Q3 2024
Forecast13.0810.0010.30
Reported-3.31-3.07-3.07
Difference-125.3%-130.7%-129.8%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

6 / 10

Revenue growth 27.8% a year over 10 years. Return on equity 116.0%.

Model fair value

173.31

From earnings 173.31, from revenue 611.18.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.